Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 2:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1465–1488 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Mild Cognitive Impairment
Interventions: AL-208, Placebo; Drug
Lead sponsor: Allon Therapeutics; Industry
Eligibility: 50 Years to 79 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 26
States / cities: Laguna Hills, California • Sacramento, California • Jacksonville, Florida + 22 more

Conditions: Heart Failure
Interventions: O2 consumption max bike test; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: d-cycloserine, glycine, placebo; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 54 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 4
States / cities: Los Angeles, California • Baltimore, Maryland • Glen Oaks, New York + 1 more

Conditions: Cardiomyopathies, Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, Restrictive Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Left Ventricular Non-compaction Cardiomyopathy
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 55 Years to 90 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: Diet regimen to induce weight loss; Other
Lead sponsor: Rockefeller University; Other
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Vestibular Disease, Vestibular Dysfunction
Interventions: Not listed
Lead sponsor: Université Catholique de Louvain; Other
Eligibility: 18 Years to 90 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Premature Ejaculation
Interventions: PSD502, contains a mixture of lidocaine and prilocaine, Placebo; Drug
Lead sponsor: Plethora Solutions Ltd; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Septic Shock
Interventions: LB1148, Placebo; Drug
Lead sponsor: Leading BioSciences, Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 26
States / cities: Mobile, Alabama • Fresno, California • Long Beach, California + 23 more

Conditions: Sensory Processing Dysfunction
Interventions: Not listed
Lead sponsor: The Spiral Foundation at OTA Watertown; Other
Eligibility: 13 Years to 95 Years
Enrollment: 1,300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Newton, Massachusetts

Conditions: Heart Failure, Diastolic
Interventions: transcutaneous vagus nerve stimulation; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Cognitive Function, Memory, Cognitive Decline
Interventions: Dietary Supplement: Brain Blossom, Placebo; Dietary Supplement
Lead sponsor: Bio Nature Health; Industry
Eligibility: 50 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Diabetes, Obese
Interventions: Lipid infusion and muscle biopsies; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Metabolic Syndrome, Coronary Microvascular Dysfunction
Interventions: Vericiguat, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 35 Years to 85 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Septic Shock
Interventions: Mild Induced Hypothermia; Procedure
Lead sponsor: Danish Procalcitonin Study Group; Other
Eligibility: 50 Years to 120 Years
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Antidepressant Induced Sexual Dysfunction
Interventions: Maca Root, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Erectile Dysfunction Following Radical Prostatectomy
Interventions: Low-Intensity Shockwave therapy (LiSWT); Device
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 45 Years to 70 Years · Male only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Impotence
Interventions: Viagra (Sildenafil Citrate) 100 mg; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 25
States / cities: Birmingham, Alabama • Homewood, Alabama • Hoover, Alabama + 22 more

Conditions: Dystonia
Interventions: TMS, MRI, VASO Imaging; Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Estrogen Deficiency, Cardiovascular Disease (CVD), Functional Hypothalamic Amenorrhea, Endothelial Dysfunction
Interventions: 17beta Estradiol, Transdermal placebo patch, Progesterone, Placebo Pill; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Spinal Cord Injuries, Cardiovascular Abnormalities, Cerebrovascular Disease; Sequelae, Cognitive Impairment
Interventions: One bout of moderate-intensity sub-maximal aerobic exercise; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 55 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Coronary Artery Disease, Atherosclerosis, Inflammation, Endothelial Dysfunction
Interventions: Rilonacept, Placebo; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Dysfunction of Eustachian Tube
Interventions: Not listed
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: Up to 18 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 9
States / cities: Palo Alto, California • Boston, Massachusetts • West Bloomfield, Michigan + 6 more

Conditions: Dry Eye Disease, Meibomian Gland Dysfunction
Interventions: IPL_RF_MGX; Device
Lead sponsor: Lumenis Be Ltd.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 2
States / cities: New York, New York • Harrisburg, North Carolina

Search by objective public record fields.

Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery

Heart Failure and a Preserved Ejection Fraction

Adjunctive Treatment for Decreasing Symptoms of Schizophrenia

Pediatric Cardiomyopathy Mutation Analysis

Evolution of Memory Related Activity

Diet Induced Weight Loss to Reduce Inflammation in Obese Women

Four Ways to Be Dizzy: When Physiology Fails to Explain Disability Insights From the UVIS International Survey

Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation

Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148

Sensory Processing Difficulties in Adults and Adolescents

Noninvasive Neuromodulation to Reserve Diastolic Dysfunction

A Clinical Trial to Investigate the Efficacy of the Brain Blossom Supplement to Improve Cognitive Function and Memory

PGC-1 and Mitochondrial Dysfunction in Diabetes

Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

The Cooling And Surviving Septic Shock Study (CASS)

Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females

Low-intensity Shockwave Therapy for Post-radical Prostatectomy Erectile Dysfunction

Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose

Pathophysiology of Focal Hand Dystonia

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury

Rilonacept to Improve Artery Function in Patients With Atherosclerosis

AERA Pediatrics Registry

Feasibility of IPL Combined With RF for Treatment of DED Due to MGD